ROYALTY PHARMA PLC- CL A (RPRX:NASDAQ)
$56.45 0.02 (0.0354%)
Analysed ROYALTY PHARMA PLC- CL A (RPRX:NASDAQ) News Sources
Why Is Agenus (AGEN) Down 9.6% Since Last Earnings Report?
10-06-2026
yahoo.com
3 Unpopular Stocks We’re Skeptical Of
12-06-2026
yahoo.com
This Royalty Pharma Insider Reduced Their Stake By 10%
12-06-2026
yahoo.com
Branded Pharmaceuticals Stocks Q1 Recap: Benchmarking Royalty Pharma (NASDAQ:RPRX)
15-06-2026
yahoo.com
Royalty Pharma, plc (RPRX) Rallied on Earnings Beat
29-06-2026
yahoo.com
Systemic Lupus Erythematosus Market at a Turning Point as 6 Late-Stage Emerging Therapies Set to Redefine Treatment Landscape | DelveInsight
09-07-2026
yahoo.com
RPRX or ACAD: Which Is the Better Value Stock Right Now?
09-07-2026
yahoo.com
Royalty Pharma PLC (RPRX) Hits Fresh High: Is There Still Room to Run?
10-07-2026
yahoo.com
Are You Looking for a Top Momentum Pick? Why Royalty Pharma (RPRX) is a Great Choice
10-07-2026
yahoo.com
Why Royalty Pharma (RPRX) Could Beat Earnings Estimates Again
10-07-2026
yahoo.com
What is the current price of ROYALTY PHARMA PLC- CL A (RPRX:NASDAQ)?
The current price of ROYALTY PHARMA PLC- CL A (RPRX:NASDAQ) is $56.45.
ROYALTY PHARMA PLC- CL A (RPRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of ROYALTY PHARMA PLC- CL A (RPRX:NASDAQ) since the previous trading day is $0.02.
ROYALTY PHARMA PLC- CL A (RPRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of ROYALTY PHARMA PLC- CL A (RPRX:NASDAQ) since the previous trading day is 0.0354%.
What is the most recent average sentiment score for ROYALTY PHARMA PLC- CL A (RPRX:NASDAQ)?
The most recent average sentiment score for ROYALTY PHARMA PLC- CL A (RPRX:NASDAQ) is 62 out of 100.
What is the most recent average sentiment for ROYALTY PHARMA PLC- CL A (RPRX:NASDAQ)?
The most recent sentiment for ROYALTY PHARMA PLC- CL A (RPRX:NASDAQ) is .
SEC-8K** Filing Available For ROYALTY PHARMA PLC- CL A (RPRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.